Search | TVST | ARVO Journals

Showing 1 – 20 of 106

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Jessica Loo; Traci E Clemons; Emily Y Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1449. doi:

ARVO Annual Meeting Abstract July 2019

Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi) – 3-year results. .

Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3858. doi:

ARVO Annual Meeting Abstract July 2019

Luminate protects against hydroquinone–induced injury in human RPE cells

Ping Yang; Samantha Erin Neal; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1944. doi:

ARVO Annual Meeting Abstract July 2019

Clinical outcomes following the triple procedure

Obi Umunakwe; Susan Wakil; Atalie C. Thompson; Glenn J Jaffe; Terry Kim; Leon Herndon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6646. doi:

ARVO Annual Meeting Abstract July 2019

Resveratrol protects against hydroquinone-induced damage in RPE cells

Samantha Erin Neal; Kristen Buehne; Peter Silinski; Ping Yang; Glenn Jaffe

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1942. doi:

New Developments in Vision Research April 2019

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

PDF

Ann-Margret Ervin; Rupert W. Strauss; Mohamed I. Ahmed; David Birch; Janet Cheetham; Frederick L. Ferris III; Michael S. Ip; Glenn J. Jaffe; Maureen G. Maguire; Etienne M. Schönbach; SriniVas R. Sadda; Sheila K. West; Hendrik P.N. Scholl; for the ProgStar Study Group
TAGS: atrophy, prospective studies, eye, stargardt's disease, spectral-domain optical coherence tomography
Trans. Vis. Sci. Tech.. 2019; 8(2):16. doi: 10.1167/tvst.8.2.16

ARVO Annual Meeting Abstract July 2018

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Benjamin J Kim; Wei Pan; Juan E Grunwald; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; Maureen G. Maguire

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3252. doi:

ARVO Annual Meeting Abstract July 2018

Deep learning-based automatic segmentation of ellipsoid zone defects in optical coherence tomography images of macular telangiectasia type 2

Jessica Loo; Leyuan Fang; David Cunefare; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1225. doi:

ARVO Annual Meeting Abstract July 2018

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Elizabeth A Sugar; Janet A Holbrook; Alyce E Burke; Glenn J Jaffe; Albert T Vitale; Janet L. Davis; Douglas A Jabs

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):417. doi:

ARVO Annual Meeting Abstract July 2018

Effect of Tec Kinases Inhibitor on Complement-mediated Release of Basic Fibroblast Growth Factor from Human RPE Cells

Ping Yang; Grace M Tewkesbury; Kristen L Buehne; Jae Yang; Peter Baciu; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2461. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel)

Traci E Clemons; Emily Y. Chew; Eleonora M Lad; Glenn J Jaffe; Sina Farsiu; Sarah Duwel; David Cunefare; Dibyendu Mukherji

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1839. doi:

ARVO Annual Meeting Abstract July 2018

Phase III studies of brolucizumab versus aflibercept in nAMD: 48-week primary and key secondary outcomes from HAWK/HARRIER

Glenn J Jaffe; Adrian H C Koh; Yuichiro Ogura; Andreas Weichselberger; Frank G. Holz; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1624. doi:

ARVO Annual Meeting Abstract July 2018

Semi-Automated Segmentation of Hyperreflective Foci on Optical Coherence Tomography

Philip DeSouza; Scott Walter; David Cunefare; Rajiv Shah; Sina Farsiu; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4855. doi:

ARVO Annual Meeting Abstract July 2018

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Emily Y. Chew; Traci E Clemons; Glenn J Jaffe; Sina Farsiu; eleonora lad; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2605. doi:

ARVO Annual Meeting Abstract July 2018

Effects of resveratrol and hydroquinone on the endoplasmic reticulum and mitochondria in human RPE cells

Kristen Buehne; Ping Yang; Glenn Jaffe

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4034. doi:

Special Issue September 2017

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

PDF

Dibyendu Mukherjee; Eleonora M. Lad; Ryan R. Vann; Stephanie J. Jaffe; Traci E. Clemons; Martin Friedlander; Emily Y. Chew; Glenn J. Jaffe; Sina Farsiu; for the MacTel Study Group
TAGS: telangiectasis, diagnostic imaging, eye, optical coherence tomography, personal integrity, spectral-domain optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2017; 58(6):BIO291-BIO299. doi: 10.1167/iovs.17-21834

Immunology and Microbiology August 2017

Fundus Autofluorescence Findings in Eyes With Birdshot Chorioretinitis

PDF

Christian Böni; Jennifer E. Thorne; Richard F. Spaide; Trucian A. Ostheimer; David Sarraf; Ralph D. Levinson; Debra A. Goldstein; Lana M. Rifkin; Albert T. Vitale; Glenn J. Jaffe; Gary N. Holland
TAGS: vision, eye, vitiliginous chorioretinitis, fundus autofluorescence imaging
Invest. Ophthalmol. Vis. Sci.. 2017; 58(10):4015-4025. doi: 10.1167/iovs.17-21897

ARVO Annual Meeting Abstract June 2017

Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Cynthia A Toth; Vincent Tai; Maxwell Pistilli; Stephanie Chiu; Katrina Winter; Ebenezer Daniel; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Gui-Shuang Ying; Sina Farsiu; Maureen G Maguire

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1195. doi:

ARVO Annual Meeting Abstract June 2017

Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Vincent Tai; Stephanie Chiu; Katrina Winter; Ebenezer Daniel; Juan E Grunwald; Maxwell Pistilli; Monica Sevilla; Gui-Shuang Ying; Glenn J Jaffe; Daniel F Martin; Sina Farsiu; Maureen G Maguire; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):870. doi:

ARVO Annual Meeting Abstract June 2017

Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT)

Gui-Shuang Ying; Maureen G Maguire; Wei Pan; Juan E Grunwald; Ebenezer Daniel; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):886. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi) – 3-year results. .

Luminate protects against hydroquinone–induced injury in human RPE cells

Clinical outcomes following the triple procedure

Resveratrol protects against hydroquinone-induced damage in RPE cells

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Deep learning-based automatic segmentation of ellipsoid zone defects in optical coherence tomography images of macular telangiectasia type 2

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Effect of Tec Kinases Inhibitor on Complement-mediated Release of Basic Fibroblast Growth Factor from Human RPE Cells

Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel)

Phase III studies of brolucizumab versus aflibercept in nAMD: 48-week primary and key secondary outcomes from HAWK/HARRIER

Semi-Automated Segmentation of Hyperreflective Foci on Optical Coherence Tomography

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Effects of resveratrol and hydroquinone on the endoplasmic reticulum and mitochondria in human RPE cells

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

Fundus Autofluorescence Findings in Eyes With Birdshot Chorioretinitis

Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials

Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT)

To View More...

You must be signed into an individual account to use this feature.